Thapa, R <br/><br/>
Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.  [electronic resource] 

 -  Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH   
 - 63-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2072-6805 
<br/><br/><label>Standard No.: </label>10.3126/nepjoph.v5i1.7824  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fundus Oculi<br/>Humans<br/>Intravitreal Injections<br/>Macular Edema--diagnosis<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Retinal Vein Occlusion--complications<br/>Time Factors<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity<br/>Young Adult